Today we're speaking with Mario Bourdon, the chief scientific officer of BioLaurus, which is innovating the future of in vivo preclinical molecular imaging by combining study design, consulting, study management, and image analytics. We will go through the BioLaurus story that Mario has taken from the ground floor to where it is today.